Skip to main content
Log in

Lymphocytotoxic autoantibodies in progressive systemic sclerosis

  • Original Contributions
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Summary

In 53 patients with progressive systemic sclerosis (PSS) the lymphocytotoxic activity of their serum was measured in a microlymphocytotoxicity assay. In 21 of the 53 patients the test reacted distinctly positively in the heterologous system, and in 9 of these 21 also in the autologous system. After preparation of the immunoglobulins from these positive sera, whole cytotoxic activity was detected only in the IgM fraction but not in the IgG fraction. When using prepared T lymphocytes as target cells in the microlymphocytotoxicity test, the cytotoxic activity of the positive PSS sera showed itself to be directed against this lymphocyte population. Further analysis using the Western-blot technique showed that the IgM autoantibody in PSS sera reacted with the cell surface of CD4+ lymphocytes. The cross reactivity with extractable nuclear antigens was rather improbable. These results suggest that lymphocytotoxic autoantibodies may play a role in immunological disturbances in PSS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bakke AC, Ehresmann GR, Horowitz DH (1985) T cell subsets in progressive systemic sclerosis: a preliminary report. In: Black CM (ed) Current topica in rheumatology: Systemic sclerosis (scleroderma). Grower Medical, New York London, pp 338–341

    Google Scholar 

  2. Boyum A (1978) Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 21:77–89

    Google Scholar 

  3. Brentnall TJ, Kenneally D, Barnett AJ (1982) Autoantibodies to fibroblasts in scleroderma. J Clin Lab Immunol 3:9–12

    Google Scholar 

  4. Burnham TK (1981) Nuclear immunofluorescent patterns in mixed connective tissue disease (MCTC). J Am Acad Dermatol 4:95–96

    Google Scholar 

  5. Cairus E, Block J, Bell DA (1984) Anti-DNA-autoantibody-producing hybridomas of normal human lymphoid cell origin. J Clin Invest 74:880–885

    Google Scholar 

  6. Cohen S, Johnson AR, Hurd E (1983) Cytotoxicity of sera from patients with scleroderma. Arthritis Rheum 26:170–178

    Google Scholar 

  7. Connelly SM, Winkelmann RK (1981) Direct immunofluorescent findings in scleroderma syndromes. Acta Derm Venereol (Stockh) 61:29–36

    Google Scholar 

  8. Duncan MR, Perlish JS, Fleischmajer R (1984) Lymphokina/monokina inhibition of fibroblast proliferation and collagen production: role in progressive systemic sclerosis (PSS). J Invest Dermatol 83:377–384

    Google Scholar 

  9. Ehresmann GR, Bakke AC, Horwitz DA (1982) T cell subsets in progressive systemic sclerosis. Arthritis Rheum 25 [Suppl]:45 (abstract)

    Google Scholar 

  10. Haustein UF, Herrmann K, Böhme HJ (1986) Pathogenesis of progressive systemic sclerosis. Int J Dermatol 5:286–293

    Google Scholar 

  11. Jarzabek-Chorzelska M, Blaszczyk M, Jabŀonska S, Chorzelski T, Kumar V, Beutner EH (1986) Scl 70 antibody —a specific marker of systemic sclerosis. Br J Dermatol 115:393–401

    Google Scholar 

  12. Krakauer RS, Sundeen J, Sauder DN, Scherbel A (1981) Abnormalities of immune regulation in progressive systemic sclerosis: evidence for excess helper-cell function and altered B-cell function. Arch Dermatol 117:80–82

    Google Scholar 

  13. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond) 277:680–685

    Google Scholar 

  14. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275

    Google Scholar 

  15. Mackel AM, De Lustro F, Harper FE, LeRoy EC (1982) Antibodies to collagen in scleroderma. Arthritis Rheum 25:522–531

    Google Scholar 

  16. Masi AT, Rodnan GP, Medsger TA jr, Altman RD, D'Angelo WA, Fries JF, LeRoy EC, Kirsner AB, Mac-Kenzie AH, McShane DJ, Myers AR, Sharp GC (1980) Preliminary criteria for the classification of systemic clerosis (scleroderma). Arthritis Rheum 23:581–590

    Google Scholar 

  17. Minota S, Winfield JB (1987) IgG anti-lymphocyte antibodies in systemic erythematosus react with surface molecules shared by peripheral T cells and a primitive T cell line. J Immunol 138:1750–1756

    Google Scholar 

  18. Miyoshi Y, Kilpatrick KA, Kelley RO, Searles RP, Williams RC (1985) Antibodies to lymphocyte membrane preparations in systemic lupus erythematosus. J Rheumatol 12:1097–1104

    Google Scholar 

  19. Reimer G, Huschka M, Keller J, Kammerer R, Hornstein OP (1983) Immunofluorescence studies in progressive systemic sclerosis (scleroderma) and mixed connective tissue disease. Br J Dermatol 109:27–36

    Google Scholar 

  20. Schaller J, Herrmann K, Haustein UF (1988) Decrease in the SE-receptors in systemic sclerosis (submitted for publication)

  21. Takehara K, Moroi Y, Ishibashi Y (1985) Antinuclear antibodies in the relatives of patients with systemic sclerosis. Br J Dermatol 112:23–33

    Google Scholar 

  22. Tan EM, Rodnan GP, Garcia I, Moroi Y, Fritzler HJ, Peables C (1980) Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome. Arthritis Rheum 23:617–625

    Google Scholar 

  23. Terasaki PI, McClelland JD (1965) Microdroplet assay of serum cytotoxine. Nature 204:998–1000

    Google Scholar 

  24. Tomonari K (1985) Invivo helper activity of autoreactive T cell clones. J Immunol 135:1598–1605

    Google Scholar 

  25. Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets. Proc Natl Acad Sci (USA) 76:4350–4354

    Google Scholar 

  26. Tuffanelli DL, Winkelmann RK (1962) Scleroderma and its relationship to the “collagenoses”: dermatomyositis, lupus erythematosus, rheumatoid arthritis and Sjögren's syndrome. Am J Med Sci 243:133–136

    Google Scholar 

  27. Tuffanelli DL, McKeon F, Kleinsmith AM, Burnham TK, Kirschner M (1983) Anticentromere and anticentriole antibodies in the scleroderma spectrum. Arch Dermatol 119:560–566

    Google Scholar 

  28. Wahl SM, Wahl LM, McCorthy JB (1978) Lymphocyte mediated activatin of fibroblast proliferation and collagen production. J Immunol 121:942–946

    Google Scholar 

  29. Winfield JB, Shaw M, Yamada A, Minota S (1987) Subset specificity of antilymphocyte antibodies in systemic lupus erythematosus. II. Preferential reactivity with T4+ cells is associated with relative depletion of autologous T4+ cells. Arthritis Rheum 30:162–168

    Google Scholar 

  30. Wybran J, Fudenberg HH (1973) Thymus derived rosette-forming cells in various human disease states: cancer, lymphoma, bacterial and viral infections and other diseases. J Clin Invest 52:1026–1032

    Google Scholar 

  31. Yamada A, Shaw M, Winfield JB (1985) Surface antigen specificity of cold-reactive IgM antilymphocyte antibodies in systemic lupus erythematosus. Arthritis Rheum 28:44–51

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Herrmann, K., Schaller, J., Haustein, U.F. et al. Lymphocytotoxic autoantibodies in progressive systemic sclerosis. Arch Dermatol Res 280, 399–404 (1988). https://doi.org/10.1007/BF00429977

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00429977

Key words

Navigation